Nutcracker Therapeutics, Inc., a contract, research, development and manufacturing organization (CRDMO) with a next ?generation RNA precision manufacturing platform, announced today that Chief ...

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Cynthia Collins to the Company’s Board ...

Cynthia Collins is a recognized leader with more than four decades of experience working in the pharmaceutical and biotech industry ... Chair and interim CEO of Nutcracker Therapeutics, a contract ...

CRISPR Therapeutics’ Julianne Bruno is hitting the exit in favor of external opportunities, marking the latest shakeup to the ...

The U.S. biotech sector had already been through a brutal few years before the latest market crash. Robert F. Kennedy Jr.’s shake-up of the nation’s health agencies and persistently high ...

Cell programming biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of therapeutics development. The decision was driven by “shifting ...

HYDERABAD: Vaccine manufacturer Bharat Biotech International Limited (BBIL) is making a foray into the cell and gene therapy (CGT) space with a vertically integrated CGT and viral production ...

In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech stocks had a “challenging” year in 2024, JPMorgan believes that some ...

The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments, and even support biodiversity research. This year’s list of biotech ...

Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and ...